InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Gorman Brian, Executive. Insider active across 1 company, notably Opiant Pharmaceuticals, INC.. Cumulatively, 10 filings have been logged. Split: 2 buys · 4 sells. Total volume traded: €97k. History available since 14 September 2021. The latest transaction was filed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
14,540 shares@ US$20.0073.7% of flowCommon StockSEC:0001385508-23-000057:0
444 shares@ US$20.262.2% of flowCommon StockSEC:0001385508-23-000032:0
1,313 shares@ US$20.206.8% of flowCommon StockSEC:0001385508-23-000009:0
691 shares@ US$11.162.1% of flowCommon StockSEC:0001385508-22-000110:0
2,000 shares0Common StockSEC:0001385508-22-000100:0
1,148 shares@ US$13.5225.6% of flowCommon StockSEC:0001385508-22-000066:0
12,000 shares0Common StockSEC:0001385508-22-000010
12,000 shares0Common StockSEC:0001385508-22-000010:0
1,300 shares@ US$19.045.7% of flowCommon StockSEC:0001385508-21-000128
Ideal exit: 11 Jun 2022 (T+270)
1,300 shares@ US$19.0437.2% of flowCommon StockSEC:0001385508-21-000128:0
Ideal exit: 11 Jun 2022 (T+270)
10 of 10 declarations
About Gorman Brian
Brian Gorman is an executive at OPIANT PHARMACEUTICALS, INC. Although no specific function is mentioned, he contributes to the leadership and strategy of the company. His role involves working on key initiatives that support the company's mission in the pharmaceutical sector. Brian Gorman is a professional committed to optimizing operations and achieving the company's objectives.
